BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25225802)

  • 1. A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.
    Martin L; Coronel J; Faulx D; Valdez M; Metzler M; Crudder C; Castillo E; Caviedes L; Grandjean L; Rodriguez M; Friedland JS; Gilman RH; Moore DA
    PLoS One; 2014; 9(9):e107258. PubMed ID: 25225802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
    Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
    Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.
    Lazarus RP; Kalaiselvan S; John KR; Michael JS
    Indian J Med Microbiol; 2012; 30(1):64-8. PubMed ID: 22361763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    Hundie GB; Woldemeskel D; Gessesse A
    PLoS One; 2016; 11(12):e0169188. PubMed ID: 28030634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.
    Makamure B; Mhaka J; Makumbirofa S; Mutetwa R; Mupfumi L; Mason P; Metcalfe JZ
    PLoS One; 2013; 8(2):e55872. PubMed ID: 23409072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
    Ejigu GS; Woldeamanuel Y; Shah NS; Gebyehu M; Selassie A; Lemma E
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
    Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
    J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
    Sanogo M; Kone B; Diarra B; Maiga M; Baya B; Somboro AM; Sarro YS; Togo ACG; Dembele BPP; Goita D; Kone A; M'Baye O; Coulibaly N; Diabate S; Traore B; Diallo MH; Coulibaly YI; Saleeb P; Belson M; Orsega S; Siddiqui S; Polis MA; Dao S; Murphy RL; Diallo S
    Clin Microbiol Infect; 2017 Jun; 23(6):408.e1-408.e6. PubMed ID: 28110049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Kelley HV; Tesfaye E; Balada-Llasat JM; Evans CA; Torrelles JB; Wang SH; Tessema B
    Int J Infect Dis; 2020 Jan; 90():213-218. PubMed ID: 31689528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.
    Nishiyama H; Aono A; Sugamoto T; Mizuno K; Chikamatsu K; Yamada H; Mitarai S
    J Microbiol Methods; 2014 Jun; 101():44-8. PubMed ID: 24717372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.
    Moore DA; Mendoza D; Gilman RH; Evans CA; Hollm Delgado MG; Guerra J; Caviedes L; Vargas D; Ticona E; Ortiz J; Soto G; Serpa J;
    J Clin Microbiol; 2004 Oct; 42(10):4432-7. PubMed ID: 15472289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus.
    Coronel J; Roper M; Mitchell S; Castillo E; Gamarra N; Drobniewski F; Luna G; Mendoza A; Moore DA
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1475-80. PubMed ID: 20937190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic-observation drug-susceptibility assay for the diagnosis of TB.
    Moore DA; Evans CA; Gilman RH; Caviedes L; Coronel J; Vivar A; Sanchez E; Piñedo Y; Saravia JC; Salazar C; Oberhelman R; Hollm-Delgado MG; LaChira D; Escombe AR; Friedland JS
    N Engl J Med; 2006 Oct; 355(15):1539-50. PubMed ID: 17035648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia.
    Lora MH; Reimer-McAtee MJ; Gilman RH; Lozano D; Saravia R; Pajuelo M; Bern C; Castro R; Espinoza M; Vallejo M; Solano M; Challapa R; Torrico F
    BMC Infect Dis; 2015 Jun; 15():222. PubMed ID: 26047953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
    Rasslan O; Hafez SF; Hashem M; Ahmed OI; Faramawy MA; Khater WS; Saleh DA; Mohamed MI; Khalifa MA; Shoukry FA; El-Moghazy EH
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):941-6. PubMed ID: 22584201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
    Raizada N; Sachdeva KS; Chauhan DS; Malhotra B; Reddy K; Dave PV; Mundade Y; Patel P; Ramachandran R; Das R; Solanki R; Wares DF; Sahu S; O'Brien R; Paramasivan CN; Dewan PK
    PLoS One; 2014; 9(2):e88626. PubMed ID: 24586360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
    Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.